Facebook
Twitter
LinkedIn
Forward
Diverticulitis: The Widening Gap between Data and Practice
This webinar is part of a series highlighting selected panel sessions from Clinical Congress 2023. In preparation for the webinar, we will encourage registered attendees to review the recorded content from the original session in Boston. This will ensure a deeper understanding of the material and allow for a more engaging discussion during the webinar. We believe this approach will enhance the overall educational experience for new and returning attendees.
Despite wide prevalence and an enormous cost to our health care system, management of diverticulitis continues to lack standardization. There is a growing gap between evidence-based practice and actual care provided to patients. This informative session is designed to bridge that gap and will be useful for any general, GI or acute care surgeon who treats diverticulitis.
Specific topics include non-operative management, the role of antibiotics in the treatment of acute, uncomplicated diverticulitis, and the role of primary anastomosis in the acute setting.
The live webinar will take place on May 2, 2024, 6:00 - 7:00 pm CT, featuring additional commentary from James Fleshman, MD, FACS, FASCRS and Steven D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng, Ed), Hon FRCS (I, Glasg, Eng).
Target Audience
- Practicing Surgeons
- Residents
- Medical Students
Learning Objectives
At the conclusion of the course, participants should be able to do the following:
- Discuss and bridge the gap between evidence-based practice and actual care provided to patients.
- Learn knowledge useful for any general, GI or acute care surgeon who treats diverticulitis.
Contact
- If you have any questions about the course, please contact Lily Scannell at email: lscannell@facs.org.
- For any technical questions, contact learning@facs.org.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
American College of Surgeons Program Committee Disclosures
Fabrizio Michelassi, MD, FACS, MAMSE - Tsumura, Inc
Brooke C. Bredbeck, MD - Nothing to disclose.
Kellie R. Brown, MD, FACS - Medtronic
Yolanda L. Colson, MD, PhD, FACS - Canon USA; Stryker
Sharmila Dissanaike, MD, FACS, FCCM - Heron Therapeutics
Cynthia D. Downard, MD, MMSc, FACS, FAAP - Nothing to disclose.
Quan-Yang Duh, MD, FACS - Nothing to disclose.
Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng (Hon), MAMSE - Nothing to disclose.
B.J. Hancock, MD, FRCSC, FACS - Nothing to disclose.
Dennis H. Kraus, MD, FACS - Nothing to disclose.
Jonathan A. Laryea, MB, ChB, FACS, FASCRS, FWACS - Nothing to disclose.
Amy E. Liepart, MD, FACS - Nothing to disclose.
Ronald V. Maier, MD, FACS, FRCSED(Hon), FCSHK(Hon), FCCS(Hon), FISS(Hon), MAMSE - Nothing to disclose.
Viraj Master, MD, PhD, FACS - Ethicon; Exelexis
Nipun B. Merchant, MD, FACS - Nothing to disclose.
Nicolas J. Mouawad, MD, MPH, MBA, FSVS, FACS, FRCS, RPVI - Nothing to disclose.
M. Timothy Nelson, MD, FACS, DABS - Nothing to disclose.
Patrick R. Reardon, MD, FACS - Nothing to disclose.
Kenneth W. Sharp, MD, FACS, MAMSE - Nothing to disclose.
Ali Tavakkoli, MB, BS, FACS - AltrixBio
Steve D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg), Hon FRCS (Eng), MAMSE - Takeda; Stryker; Baxter; Becton Dickinson; Arc/Corvus; GI Supply; Icon Clinical Research Ltd; Intuitive Surgical; Medtronic; Karl Storz Endoscopy
Faculty Disclosures
Alessandro Fichera, MD, FACS - Nothing to disclose.
Patricia Sylla, MD, FACS - Olympus; Ethicon; Medtronic; RedDress; GI Windows; Safeheal; Stryker
Marylise Boutros, MD, FACS - Minogue; Stryker; Johnson and Johnson
Robert N. Goldstone, MD, FACS - Nothing to disclose.
Dana M. Hayden, MD, FACS - Nothing to disclose.
Hanjoo Lee, MD, FACS - Nothing to disclose.
James Fleshman, MD, FACS, FASCRS - Cambridge Medical Robotics
Steven D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng, Ed), Hon FRCS (I, Glasg, Eng) - Takeda; Stryker; Baxter; Becton Dickinson; Arc/Corvus; GI Supply; Icon Clinical Research Ltd; Intuitive Surgical; Medtronic; Karl Storz Endoscopy
Continuing Medical Education Credit Information
Accreditation
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this Other activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Credit Claiming Information
ALL ATTENDEES MUST COMPLETE THE COURSE EVALUATION in order to claim a CME Certificate or a Certificate of Completion. The course evaluation will appear once you take and complete this course. The following requirements will need to be completed:
- Review all course materials
- Course evaluation
Available Credit
- 2.50 AMA PRA Category 1 Credit™
- 2.50 Certificate of Completion
Course Fee and Registration
The following is the course fee for each category. You will be asked to register for the course and provide payment information to complete the registration process.
- Clinical Congress attendees/Medical students - complimentary
- Resident members - $20
- Fellows and Affiliate MD/DO - $55
- Non-members - $75
Once you have completed the registration process, an email will be sent to you with the confirmation and login information to the Zoom webinar.
To Start Course
Once you have completed the registration process, you will see the "Take Course" button above. Click on the button to start/access the educational activity.
Prior to the live webinar on May 2, 2024, 6:00 - 7:00 pm CT, review the recorded content from the original session in Boston on the course page. After the live webinar, return to the course page to access the enduring webinar recording, complete the course evaluation, and claim your certificate (if applicable).